Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesco Mendicino

Showing results (1-10 of 79) with videos related to

Pageof 8
Sort By:
Clinical Lymphoma, Myeloma & Leukemia|June 3, 2020
Splenectomy in Myelofibrosis: Indications, Efficacy, and ComplicationsAlessandra Malato, Elena Rossi, Mario Tiribelli, et al.
Frontiers in Oncology|December 3, 2019
Mechanisms Underlying the Anti-inflammatory and Immunosuppressive Activity of RuxolitinibElena Maria Elli, Claudia Baratè, Francesco Mendicino, et al.
Frontiers in Sociology|May 25, 2023
Contributions of digital social research to develop Telemedicine in Calabria (Southern Italy): identification of inequalities in post-COVID-19Luciana Taddei, Francesco Mendicino, Teresa Grande, et al.
European Journal of Haematology|June 19, 2015
Bendamustine in multiple myelomaMassimo Gentile, Ernesto Vigna, Anna Grazia Recchia, et al.
Panminerva Medica|September 21, 2020
Chemotherapy-based regimens in multiple myeloma in 2020Massimo Gentile, Fortunato Morabito, Massimo Martino, et al.
Cancers|July 2, 2021
Mechanisms of Immune Evasion in Multiple Myeloma: Open Questions and Therapeutic OpportunitiesCirino Botta, Francesco Mendicino, Enrica Antonia Martino, et al.
European Journal of Haematology|June 23, 2025
Treatment-Free Remission in Chronic Myeloid Leukemia: Revisiting the "W" QuestionsAntonella Bruzzese, Ernesto Vigna, Enrica Antonia Martino, et al.
European Journal of Haematology|October 17, 2023
Teclistamab-cqyv in multiple myelomaEnrica Antonia Martino, Antonella Bruzzese, Caterina Labanca, et al.
Current Oncology (Toronto, Ont.)|July 25, 2022
Management of Myelofibrosis during Treatment with Ruxolitinib: A Real-World Perspective in Case of Resistance and/or IntoleranceMassimo Breccia, Francesca Palandri, Paola Guglielmelli, et al.
Frontiers in Oncology|January 25, 2021
COVID-19: High-JAKing of the Inflammatory "Flight" by Ruxolitinib to Avoid the Cytokine StormCirino Botta, Alessia Indrieri, Eugenio Garofalo, et al.
Pageof 8

Showing results (1-10 of 79) with videos related to

Sort By:
Pageof 8
Clinical Lymphoma, Myeloma & Leukemia|June 3, 2020
Splenectomy in Myelofibrosis: Indications, Efficacy, and ComplicationsAlessandra Malato, Elena Rossi, Mario Tiribelli, et al.
Frontiers in Oncology|December 3, 2019
Mechanisms Underlying the Anti-inflammatory and Immunosuppressive Activity of RuxolitinibElena Maria Elli, Claudia Baratè, Francesco Mendicino, et al.
Frontiers in Sociology|May 25, 2023
Contributions of digital social research to develop Telemedicine in Calabria (Southern Italy): identification of inequalities in post-COVID-19Luciana Taddei, Francesco Mendicino, Teresa Grande, et al.
European Journal of Haematology|June 19, 2015
Bendamustine in multiple myelomaMassimo Gentile, Ernesto Vigna, Anna Grazia Recchia, et al.
Panminerva Medica|September 21, 2020
Chemotherapy-based regimens in multiple myeloma in 2020Massimo Gentile, Fortunato Morabito, Massimo Martino, et al.
Cancers|July 2, 2021
Mechanisms of Immune Evasion in Multiple Myeloma: Open Questions and Therapeutic OpportunitiesCirino Botta, Francesco Mendicino, Enrica Antonia Martino, et al.
European Journal of Haematology|June 23, 2025
Treatment-Free Remission in Chronic Myeloid Leukemia: Revisiting the "W" QuestionsAntonella Bruzzese, Ernesto Vigna, Enrica Antonia Martino, et al.
European Journal of Haematology|October 17, 2023
Teclistamab-cqyv in multiple myelomaEnrica Antonia Martino, Antonella Bruzzese, Caterina Labanca, et al.
Current Oncology (Toronto, Ont.)|July 25, 2022
Management of Myelofibrosis during Treatment with Ruxolitinib: A Real-World Perspective in Case of Resistance and/or IntoleranceMassimo Breccia, Francesca Palandri, Paola Guglielmelli, et al.
Frontiers in Oncology|January 25, 2021
COVID-19: High-JAKing of the Inflammatory "Flight" by Ruxolitinib to Avoid the Cytokine StormCirino Botta, Alessia Indrieri, Eugenio Garofalo, et al.
Pageof 8